Literature DB >> 6600215

Characterization of interleukin 2-dependent cytotoxic T-cell clones: specificity, cell surface phenotype, and susceptibility to blocking by Lyt antisera.

M A Palladino, Y Obata, E Stockert, H F Oettgen.   

Abstract

Cytotoxic T-cells were derived from the peritoneal cavity of a C57BL/6 mouse immunized with BALB/c sarcoma Meth A and from the spleens of BALB/c x C57BL/6 F1 (hereafter called CB6F1) mice immunized with BALB/c leukemia RL male 1. The cells were cultured in interleukin 2 and cloned by limiting dilution, and their specificity was determined by direct tests and competitive inhibition assays. C57BL/6 anti-Meth A effector cells recognized H-2Dd determinants. CB6F1 anti-RL male 1 effector cells recognized a unique cell surface antigen of leukemia RL male 1. The specificity was maintained in long-term culture. The cell surface phenotype of the cloned effector cell lines as determined by absorption analysis was Thy-1.2+, Lyt-1.2+, 2.2+, and 3.2+. Cytotoxicity was blocked at the target cell level by antisera against H-2Dd, but not H-2Dk or H-2b, and at the effector cell level by antisera against Lyt-2.2 and 3.2, but not Lyt-1.2, Ly-5.1 or Thy-1.2.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6600215

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Functional channel formation associated with cytotoxic T-cell granules.

Authors:  J D Young; C F Nathan; E R Podack; M A Palladino; Z A Cohn
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

2.  Extracellular release of lymphocyte cytolytic pore-forming protein (perforin) after ionophore stimulation.

Authors:  J D Young; L G Leong; C C Liu; A Damiano; Z A Cohn
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

3.  Specific adoptive immunotherapy of malignant glioma with long-term cytotoxic T lymphocyte line expanded in T-cell growth factor. Experimental study and future prospects.

Authors:  T Yamasaki; H Handa; J Yamashita; Y Watanabe; Y Namba; M Hanaoka
Journal:  Neurosurg Rev       Date:  1984       Impact factor: 3.042

4.  Cloning and expression of the recombinant mouse natural killer cell granzyme Met-ase-1.

Authors:  J M Kelly; M D O'Connor; M D Hulett; K Y Thia; M J Smyth
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

5.  Effector mechanisms of syngeneic anti-tumour responses in mice. II. Cytotoxic T lymphocytes mediate neutralization and rejection of radiation-induced leukaemia RL male 1 in the nude mouse system.

Authors:  A Keyaki; K Kuribayashi; S Sakaguchi; T Masuda; J Yamashita; H Handa; E Nakayama
Journal:  Immunology       Date:  1985-09       Impact factor: 7.397

6.  Dendritic cells initiate a two-stage mechanism for T lymphocyte proliferation.

Authors:  J M Austyn; R M Steinman; D E Weinstein; A Granelli-Piperno; M A Palladino
Journal:  J Exp Med       Date:  1983-04-01       Impact factor: 14.307

7.  Resistance of cytolytic lymphocytes to perforin-mediated killing. Induction of resistance correlates with increase in cytotoxicity.

Authors:  C C Liu; S Jiang; P M Persechini; A Zychlinsky; Y Kaufmann; J D Young
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

8.  Epitopes on H-2Dd somatic cell mutants recognized by cytotoxic T cells.

Authors:  T A Potter; M A Palladino; D B Wilson; T V Rajan
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307

9.  Resistance of cloned cytotoxic T lymphocytes to cell-mediated cytotoxicity.

Authors:  A Blakely; K Gorman; H Ostergaard; K Svoboda; C C Liu; J D Young; W R Clark
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

10.  Biological and antigenic similarities of murine interferon-gamma and macrophage-activating factor.

Authors:  L P Svedersky; C V Benton; W H Berger; E Rinderknecht; R N Harkins; M A Palladino
Journal:  J Exp Med       Date:  1984-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.